Difference between revisions of "PDFF Biomarker Ctte"
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
| + | *[[Media:2018_02-01_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|February 1, 2018]] | ||
*[[Media:2018_01-04_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|January 4, 2018]] | *[[Media:2018_01-04_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|January 4, 2018]] | ||
*[[Media:2017_11-02_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|November 2, 2017]] | *[[Media:2017_11-02_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|November 2, 2017]] | ||
| − | |||
'''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | '''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | ||
Revision as of 22:24, 1 March 2018
- Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD
- Secretary: Susan Weinmann
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF.
Meetings
Approved call summaries:
PDFF Biomarker Committee Call Summaries Archive